Dry herb vaporizers are increasingly discussed in Australia as access to prescribed medicinal cannabis expands. However, the legal status of a dry herb vaporizer depends heavily on how it is classified, imported, supplied, and prescribed. In January 2025, the Therapeutic Goods Administration (TGA) introduced major regulatory updates that significantly changed how dry herb vaporizer devices are treated under Australian law. These changes also affect the approval process for any updated version of existing vaporizer devices, ensuring that newer models meet the latest safety and compliance standards. This article explains the current framework in a clear, factual way.

Overview of Australian regulations for dry herb vaporizers

On 29 January 2025, the TGA updated all regulations governing the importation and supply of Therapeutic Cannabis Vaping Devices, including any dry herb vaporizer intended for use with prescribed medicinal cannabis flower.

These updates were designed to:

• Improve patient safety

• Eliminate ambiguity around device labelling

• Align vaporizer regulation with existing medical device standards

All official guidance and regulatory documentation can be found via the TGA Medicinal Cannabis Hub.

It is important to understand that in Australia, a dry herb vape, weed vape, or dry herb vaporizer Australia products are no longer legally available in a retail setting. Each unit must comply with the new regulations, regardless of its design or intended use. These devices are now regulated as medical devices. The range of devices covered includes both portable and desktop models intended for medicinal cannabis use.

Vaporizers registered on the ARTG

The Australian Register of Therapeutic Goods (ARTG) is the central register for all medical devices approved for legal supply in Australia. A medical vaporiser is a device specifically designed and approved for the vaporisation, and then inhalation of medical cannabinoids, and must be listed on the ARTG for legal use in medical cannabis treatment.

Currently, the only therapeutic cannabis vaporizers registered on the ARTG are the Volcano MEDIC 2 and Mighty Plus MEDIC. The Volcano MEDIC 2 is a desktop vaporiser intended for use in clinical or home settings, while the Mighty MEDIC is a portable device. Both devices are intended for the vaporisation and then administration of medical cannabinoids derived from cannabis flower via inhalation.

What pharmacies can legally stock and sell

The only vaporizers that pharmacies can legally hold in stock in their pharmacy, and sell directly to patients over the counter, without additional paperwork, are vaporizers registered on the ARTG as medical devices.

The TGA’s position is clear:

• Patients should only use vaporizers registered on the ARTG

• ARTG registration confirms compliance with strict safety standards

• These devices are assessed as safe for therapeutic use and are designed to support reliable dose administration for patients using medicinal cannabis

Currently approved ARTG vaporizers

As of now, there are only two vaporizer devices registered on the ARTG:

• Mighty Plus MEDIC - (ARTG 319028), a portable medical vaporiser included on the ARTG

• Volcano MEDIC 2 - (ARTG 319028), a desktop medical vaporiser included on the ARTG

Both devices are manufactured to medical-grade standards and are designed specifically for vaporising ground cannabis flowers for medicinal use.

Related accessories such as Mighty MEDIC accessories, a Mighty water pipe adapter, or a bubbler water pipe are compatible with the approved devices, and are all available for sale at Sydney Vaporizers, ensuring optimal performance and safety.

Medical device classification and safety standards

Any medical device that administers medication via the respiratory system is classified as a Class IIa medical device in Australia.

These standards ensure the safe and effective delivery of active ingredients, such as cannabinoids, in medicinal cannabis products.

What Class IIa classification involves

To achieve Class IIa ARTG registration, manufacturers must:

• Have production facilities certified by one of five international regulatory bodies:

• TGA (Australia)

• FDA (United States)

• European Health authorities

• Health Canada

• Japan Health authorities

• Meet international medical electrical safety standards

• Submit devices to clinical testing to validate their intended therapeutic use

Because the Mighty Medic, Mighty Plus Medic vaporizer, and Volcano MEDIC 2 vaporizer models meet these requirements, the TGA recognises them as safe and compliant for patient use. Features such as a ceramic heating chamber and direct contact heating elements further support compliance by ensuring even heat distribution, enhanced flavor preservation, and efficient extraction of active compounds, all of which contribute to the devices' safety and performance standards.

Unapproved Therapeutic Cannabis Vaping Devices (UTVD)

While ARTG registration is the gold standard, the TGA has created a limited pathway for other devices to enter Australia under strict controls. This pathway applies to both desktop and portable devices, such as: Tinymight 2, Arizer Solo 3, Arizer Solo 2, Arizer XQ2, Arizer Air MAX, Arizer Air SE, Fenix Pro, Fenix Mini, Fenix 2Plus, Pax 2, Pax 3, Xmax Starry, Xvape Fog, and the Ball vape range from Cannabis Hardware.

Any vaporizer that is Legally imported through this pathway and is NOT registered on the ARTG, is now considered to be an: 'Unapproved Therapeutic Vaping Device' (UTVD)

Importing unapproved devices

An Australian licensed business may import a vaporizer that is not ARTG registered if:

1. The Licensed importer declares compliance with the Australian Essential Principles Guidelines (AEPG)

2. The declaration is submitted to and accepted by the TGA

3. An item number is issued by the TGA

4. A permit is granted by the Office of Drug Control (ODC) to the licensed importer

These permits are valid for 12 months only.

UTVD MUST remain in the Licensed importers secure warehouse, until a SAS-B approval is issued from the TGA for the UTVD, for the patient.

Importers of 'UTVD' must report 6monthly to the ODC as to where the stock is located. If not in the licensed importers secure warehouse, then the importer must provide evidence of the SAS-B approval for the sale

Labelling and terminology requirements

Approximately one-third of the AEPG focuses on labelling and instructions. Under current law:

• Devices must state “FOR USE WITH MEDICINAL CANNABIS FLOWER ONLY”

• User manuals must repeat this wording clearly and consistently

• User manuals must also provide clear instructions for regular cleaning, including the safe use of alcohol as a cleaning agent where appropriate.

• Devices labelled as:

• “Dry herb vaporizer”

• “Dry herb vape”

• “Aromatherapy vaporizer”

are now illegal to import, distribute, or sell in any setting (both wholesale and retail) in Australia.

This is a critical distinction for anyone searching for a dry herb vaporizer Australia, weed vapes or dry herb vape Australia.

Storage, reporting, and penalties for UTVD

Once legally imported, all Unapproved Therapeutic Vaping Devices (UTVD) must:

• Remain in the licensed importer’s secure warehouse

• Not be supplied unless a SAS-B approval has been granted

• Report to the ODC every six months, stating the location of all UTVD imported (If sold, the SAS-B approval must also be submitted)

These devices are intended for the vaporization and then inhalation of medicinal cannabis, subject to regulatory approval.

Penalties for non-compliance

Licensed importers who knowingly breach these regulations face:

• Fines of up to $1 million

• Prison sentences of up to 7 years

These penalties reflect the seriousness of medical device regulation in Australia.

 

---

 

SAS-B approvals for unapproved vaporizers

A Special Access Scheme Category B (SAS-B) approval is the only legal pathway for a patient to receive an unapproved therapeutic cannabis vaporizer.

How SAS-B approvals work

• The patient must consult an Authorised Prescriber

• The prescriber submits a SAS-B application to the TGA

• The prescriber must give clinical reason as to why the patient cannot use a vaporizer that IS registered on the ARTG (Mighty+ MEDIC, Volcano MEDIC 2)

• The application must specify the exact UTVD device

• Clinical justification is required

• TGA has made it clear that SAS-B approvals will ONLY be granted if clinical justification is presented

Fenix Pro, Fenix Mini, Tinymight 2, Arizer Solo 3, Arizer Solo 2, Xmax Starry 2, and Fenix Neo vaporizers may be considered as alternatives under SAS-B approval, depending on clinical justification.

Clinical justification requirements

The prescriber must clearly explain why the patient cannot use:

• The Mighty Plus MEDIC, or

• The Volcano MEDIC 2

The TGA has explicitly stated that SAS-B approvals will only be granted where clinical evidence supports the need for an alternative device.

Until approval is issued:

• The UTVD must remain in the importer’s warehouse

• It cannot be supplied, displayed, advertised or sold

Public vaping laws and restrictions

Public vaping laws and restrictions in Australia are shaped by both federal and state regulations, making it essential for users of portable dry herb vaporizers to stay informed about the rules in their specific area. For patients prescribed medicinal cannabis, the use of portable vaporizers is generally permitted in public spaces where smoking is allowed, provided that the user has a valid prescription and adheres strictly to the prescribed dosage. However, it is important to use vaping devices responsibly to avoid causing discomfort to others and to minimize the risk of passive inhalation, especially around children.

Across Australia, many states and territories have implemented restrictions on vaping in enclosed public spaces such as restaurants, shopping centers, and public transport. These laws are designed to protect public health and align the use of vaporizers with existing smoking regulations. As such, before using a dry herb vaporizer in any public setting, patients should confirm the local laws and always carry their prescription and identification to demonstrate legal compliance if questioned.

In medical practices and hospital settings, only TGA-approved medical vaporisers should be used for the administration of medicinal cannabis. These devices, such as those from Storz & Bickel, are engineered for safety and reliability, featuring advanced technologies like ceramic heating chambers, convection vaporizers, and precise temperature control. Such features ensure that active compounds are vaporized efficiently without combustion, supporting both patient safety and therapeutic effectiveness.

When selecting a portable vaporizer for medicinal cannabis, patients should consider key features such as battery life, temperature settings, dosing capsules, and compatibility with USB-C charging. Brands like Storz & Bickel and DynaVap are recognized for their quality, offering devices with haptic feedback and superior performance tailored to individual preferences. Choosing a vaporizer with precise temperature control not only enhances the inhalation experience but also helps maintain compliance with medical guidelines.

Ultimately, understanding and respecting public vaping laws is crucial for all medicinal cannabis patients in Australia. By choosing high-quality, ARTG registered vaporizers, following prescribed dosages, and using devices responsibly, patients can ensure a safe, effective, and compliant medicinal cannabis experience wherever they are permitted to vape.

Final thoughts on dry herb vaporizers in Australia

Australia now has one of the strictest regulatory frameworks in the world for 'dry herb vaporizer' devices. While this has limited the availability of non-approved products, it has also created a clear, safety-focused pathway for patients and healthcare professionals.

Devices such as the Mighty Plus MEDIC and Volcano MEDIC 2 represent the current benchmark, while all other Unapproved Therapeutic Cannabis vaporizers are tightly controlled under SAS-B regulations. Understanding these laws is essential for patients, prescribers, clinics, importers, and pharmacies operating in the Australian medicinal cannabis space.